Sionna Therapeutics Inc.

This early-stage study is testing the safety of new drug combinations for cystic fibrosis in healthy volunteers. Researchers want to understand what side effects might occur and how the drugs move through the body when taken together. The study involves 144 healthy adults who wil…

This study is testing if adding an experimental drug called SION-719 to the standard medication Trikafta is safe and works better for people with cystic fibrosis who have a specific genetic type. It will involve about 16 people who are already taking Trikafta. Researchers will ch…